Notch Therapeutics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 6

Notch Therapeutics General Information

Description

Developer of immunotherapy drugs designed to generate T cells and other immune cells from clonal stem cell lines. The company's products uniform, stem cell-derived, gene-edited immune cell therapies and differentiation of induced pluripotent stem cells in fully defined, feeder-free, and serum-free cultures into mature T cells, enabling doctors to create cell banks for thousands of patients

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 40 King Street West
  • Suite 2100
  • Toronto, Ontario M5H 3C2
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Notch Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 00.000 Completed Generating Revenue
1. Seed Round 01-Nov-2019 00.000 00.000 Completed Generating Revenue
To view Notch Therapeutics’s complete valuation and funding history, request access »

Notch Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Juan Zúñiga-Pflücker Ph.D Co-Founder
Peter Zandstra Ph.D Co-Founder
David Main President & Chief Executive Officer
Kamran Alam Executive Vice President, Finance and Chief Financial Officer
Ulrik Nielsen Ph.D Executive Chairman
To view Notch Therapeutics’s complete executive team members history, request access »

Notch Therapeutics Board Members (1)

Name Representing Role Since
Ulrik Nielsen Ph.D Self Executive Chairman 000 0000
To view Notch Therapeutics’s complete board members history, request access »

Notch Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Allogene Therapeutics Corporation Minority 000 0000 000000 0
Centre for Commercialization of Regenerative Medicine Corporation Minority 000 0000 000000 0
Lumira Ventures Venture Capital Minority 000 0000 000000 0
Sunnybrook Health Sciences Centre VC-Backed Company Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »